Autore	Gruffydd-Jones Kevin
Pubbl/distr/stampa	London, : Cedilla Pub. Ltd., 2008
Descrizione fisica	1 online resource (74 p.)
Disciplina	616.24
Collana	The 10-minute consultation
Soggetto topico	Lungs - Diseases, Obstructive
Soggetto genere / forma	Electronic books.
ISBN	1-905982-14-3
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	9781905982141; Outside front cover; Title page; Copyright page; Contents; Chapter 1 Introduction; Chapter 2 Who and what to test; Chapter 3 How to manage the patient with COPD; Chapter 4 Person-centred care; Chapter 5 Applying the evidence; Chapter 6 Review and recall of the patient with COPD; Further reading; Outside back cover
Record Nr.	UNINA-9910462028903321

Autore	Gruffydd-Jones Kevin
Edizione	[1st ed.]
Pubbl/distr/stampa	London, : Cedilla Pub. Ltd., 2008
Descrizione fisica	1 online resource (74 p.)
Disciplina	616.24
Collana	The 10-minute consultation
Soggetto topico	Lungs - Diseases, Obstructive
ISBN	1-905982-14-3
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	9781905982141; Outside front cover; Title page; Copyright page; Contents; Chapter 1 Introduction; Chapter 2 Who and what to test; Chapter 3 How to manage the patient with COPD; Chapter 4 Person-centred care; Chapter 5 Applying the evidence; Chapter 6 Review and recall of the patient with COPD; Further reading; Outside back cover
Record Nr.	UNINA-9910815162003321

Edizione	[Third edition.]
Pubbl/distr/stampa	Hoboken, New Jersey : , : Wiley Blackwell : , : BMJ Books, , 2017
Descrizione fisica	1 online resource (120 pages) : color illustrations
Disciplina	616.24
Collana	ABC Series
Soggetto topico	Lungs - Diseases, Obstructive
Soggetto genere / forma	Electronic books.
ISBN	1-119-21281-2 1-119-21280-4
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	Definition, epidemiology and risk factors -- Pathology and pathogenesis -- Diagnosis -- Lung function tests -- Smoking cessation -- Non-pharmacological management -- Pharmacological management (I). Inhaled treatment -- Pharmacological management (II). Oral treatment -- Drug delivery devices -- Oxygen -- Surgical and interventional strategies -- Exacerbations -- Ventilatory support -- Primary care -- Death, dying and end of life issues -- Future treatments.
Record Nr.	UNINA-9910466603003321

Pubbl/distr/stampa	Washington, DC : , : U.S. Environmental Protection Agency, , [2005]
Descrizione fisica	1 online resource (2 pages) : digital, PDF file
Collana	United States Environmental Protection Agency fact sheet
Soggetto topico	Asthma Lungs - Diseases, Obstructive Asthma in old age
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Altri titoli varianti	Age healthier, breathe easier
Record Nr.	UNINA-9910699266403321

Pubbl/distr/stampa	London ; ; Malden, MA, : Blackwell Science, 2002
Descrizione fisica	1 online resource (410 p.)
Disciplina	616.2/38 616.238
Altri autori (Persone)	JohnstonSebastian L HolgateS. T
Collana	Challenges In
Soggetto topico	Asthma Lungs - Diseases, Obstructive
ISBN	1-281-31020-4 9786611310202 0-470-69388-6 0-470-69310-X
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	Asthma; Contents; List of contributors; Preface; Acknowledgements; Part 1: Epidemiology; 1 P.M.MATRICARDI AND S. BONINI: Why is the incidence of asthma increasing?; 2 E. VON MUTIUS: Why is asthma more common in the West?; 3 R. BEASLEY, J. DOUWES, J. PEKKANEN AND N.E. PEARCE: How much asthma can be attributed to atopic sensitization?; 4 A.J. CHAUHAN: Is air pollution important in asthma?; Part 2: Pathophysiology; 5 E.R. SUTHERLAND AND R.J. MARTIN: Is infection important in the pathogenesis and clinical expression of asthma? 6 B. BJORKSTEN: Does infection in early life protect against or cause asthma?7 S.T. WEISS: Does asthma progress to chronic obstructive pulmonary disease?; 8 P.G. WOODRUFF, S.L. PRESCOTT, P.G. HOLT AND J.V. FAHY: Antenatal factors in the development of atopy and asthama?; 9 I. SAYERS, B. BEGHE, J. HOLLOWAY AND S.T. HOLGATE: Genetics of asthma: what's new?; Part 3: Treatment; 10 D. SMALLWOOD AND J. WILSON: Can airway fibrosis be prevented?; 11 A. CUSTOVIC AND A. WOODCOCK: Does allergen avoidance help? What are the practical measures that patients can take? 12 P.J. HELMS: Is early treatment of children necessary?13 P.J. BARNES: What are the mechanisms of corticosteroid resistance in asthma?; 14 J.C. KIPS, K.G. TOURNOY AND R.A. PAUWELS: What new therapies are being developed for asthma and will they offer something better than steroids?; 15 M.R . SEARS: What is the role of long-acting (32-agonists in the treatment of asthma?; 16 M.E. WECHSLER AND J.M. DRAZEN: What is the role of leukotriene modifiers in the treatment of asthma?; Part 4: Delivery of Care; 17 D. PRICE: What are the issues in delivering care in primary care? 18 B.D.W. HARRISON AND S.M. MILDENHALL: Are asthma clinics useful: should they be run by the doctor or the nurse?19 M.R. PARTRIDGE: Should asthma be managed by the patient or the doctor: is education important?; 20 B.D.W. HARRISON AND S.M. MILDENHALL: Are psychosocial factors important in asthma?; Index
Record Nr.	UNINA-9910145750403321